Report on the risk assessment of methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate (5F-MDMB-PINACA) in the framework of the Council Decision on new psychoactive substances 16. July 2018, section EUDA news
18. June 2026 EUDA annual activity report 2025: first full year under expanded mandate The European Union Drugs Agency (EUDA) today released its Consolidated Annual Activity Report 2025, capturing the...